Network origin in U. Fuhs first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 22 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to U. Fuhs via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Investor Relations Contact | |
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member | |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| ARIDIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Pepperdine University | College/University | Masters Business Admin | |
| Technische Universität München | College/University | Doctorate Degree | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| University of California, Santa Barbara | College/University | Undergraduate Degree | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Williams College | College/University | Undergraduate Degree | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL. | Investment Managers | Corporate Officer/Principal | |
| Ayer Capital Partners Master Fund LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Mezzanine Partners Management LLC (Brookside Capital Partners) is a private equity firm founded in 1977 by John N Irwin and David D Buttolph. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Director/Board Member |
Statistics
International
| United States | 44 |
| China | 2 |
| Germany | 2 |
| Cayman Islands | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 5 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 136 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 37 |
| Chief Tech/Sci/R&D Officer | 30 |
| Founder | 25 |
Most connected contacts
| Insiders | |
|---|---|
| James Topper | 52 |
| Peter Thompson | 39 |
| Xiang Ming Cui | 31 |
| Jay Venkatesan | 30 |
| Robert Conway | 21 |
| Jan Hillson | 16 |
| Mitchell Gold | 15 |
| Andrew Sandler | 12 |
| Christopher Peetz | 11 |
| Wayne Gombotz | 9 |
| Jörn Drappa | 9 |
| Stanford Peng | 9 |
| James Rickey | 8 |
| Remy Durand | 7 |
| Natasha Hernday | 7 |
- Stock Market
- Insiders
- U. Fuhs
- Company connections
